Vaginal Candidiasis More Likely With Realworld Use Of Sglt2 Inhibitors Vs Clinical Trials | Latest News RSS feed

Vaginal Candidiasis More Likely With Realworld Use Of Sglt2 Inhibitors Vs Clinical Trials - Latest News


Vaginal candidiasis more likely with real-world use of SGLT2 inhibitors vs. clinical trials

Women with type 2 diabetes who begin taking SGLT2 inhibitors are at higher risk for developing vaginal candidiasis and symptomatic vaginitis than clinical trials previously indicated, according to stu... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us